Humanin, a mitochondria-derived peptide, activates AMPK-dependent mitophagy in retinal pigment epithelium cells, enhancing clearance of amyloid-beta-damaged mitochondria and preserving retinal function. This mechanism addresses a primary driver of age-related macular degeneration and suggests a therapeutic pathway for vision preservation in aging.
Key Points
- Humanin activates AMPK to trigger selective mitochondrial autophagy in retinal cells
- Enhanced mitochondrial clearance prevents Aβ accumulation and oxidative damage
- RPE barrier integrity and retinal function preserved despite amyloid challenge
Longevity Analysis
Vision loss in aging reflects cumulative mitochondrial dysfunction and failed cellular cleanup mechanisms. Humanin targets the intersection of these two processes—restoring the cell's capacity to identify and remove damaged organelles before they propagate oxidative stress and compromise barrier function. This approach addresses a fundamental aging mechanism: the progressive decline in cellular quality control. Rather than treating symptoms downstream, activating mitophagy upstream offers a means to intercept degeneration at the point of cellular decision-making, with implications extending beyond the retina to tissues where similar mitochondrial burden contributes to age-related decline.
Original published by Wiley Aging Cell, by Ha Young Jang, Suyeon Choi, Soo‐Jin Kim, Sooyun Kim, Dong Hyun Jo, Tae Geol Lee, Kyu‐Sang Park, Jeong Hun Kim .